Fischell Department of Bioengineering/University of Maryland, United States
Disclosure information not submitted.
Lymph node therapeutics stop Type 1 Diabetes by promoting Rapamycin-dependent long-lived Treg populations
Thursday, October 9, 20253:45 PM - 4:00 PM PDT